p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases
- PMID: 1346931
- PMCID: PMC48443
- DOI: 10.1073/pnas.89.4.1330
p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases
Abstract
The protein product of the neu protooncogene, p185c-neu, is structurally similar to the epidermal growth factor receptor (EGFR). Overexpression of these two receptor tyrosine kinases, but not either separately, leads to transformation and tumorigenicity. Heterodimerization of p185c-neu and EGFR occurs in M1 cells, which express both receptors. We have individually identified the two components of the heterodimer as EGFR and p185c-neu. Analysis of this association with relatively nondenaturing detergents and in the absence of cross-linkers indicates that noncovalent interactions are primarily responsible for heterodimer formation. The rapid reversible heterodimerization was promoted by EGF binding to its receptor. Functionally, the heterodimer is a highly active protein kinase for receptor autophosphorylation and exogenous substrate phosphorylation in vitro. The isolated heterodimer was highly phosphorylated on tyrosine residues in vivo. These results indicate that the physical association between EGFR and p185c-neu is of functional significance and define enzymatic features of complex receptor formation.
Similar articles
-
Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1500-4. doi: 10.1073/pnas.91.4.1500. Proc Natl Acad Sci U S A. 1994. PMID: 7509075 Free PMC article.
-
Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.Cell. 1989 Jul 28;58(2):287-92. doi: 10.1016/0092-8674(89)90843-x. Cell. 1989. PMID: 2568888
-
Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation.Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1711-5. doi: 10.1073/pnas.91.5.1711. Proc Natl Acad Sci U S A. 1994. PMID: 7907421 Free PMC article.
-
Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy.J Cell Biochem. 1993 Sep;53(1):61-73. doi: 10.1002/jcb.240530108. J Cell Biochem. 1993. PMID: 7901229 Review.
-
The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.Oncogene. 1994 Aug;9(8):2109-23. Oncogene. 1994. PMID: 7913542 Review.
Cited by
-
Protein quantification from complex protein mixtures using a proteomics methodology with single-cell resolution.Proc Natl Acad Sci U S A. 2001 May 8;98(10):5497-502. doi: 10.1073/pnas.101124598. Epub 2001 Apr 24. Proc Natl Acad Sci U S A. 2001. PMID: 11320219 Free PMC article.
-
Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors.Immunol Res. 1998;17(1-2):179-89. doi: 10.1007/BF02786443. Immunol Res. 1998. PMID: 9479580 Review.
-
Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation.Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9220-5. doi: 10.1073/pnas.1633546100. Epub 2003 Jul 16. Proc Natl Acad Sci U S A. 2003. PMID: 12867596 Free PMC article.
-
Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.Biochem J. 1998 Aug 15;334 ( Pt 1)(Pt 1):189-95. doi: 10.1042/bj3340189. Biochem J. 1998. PMID: 9693119 Free PMC article.
-
Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.Biochem J. 1993 Mar 1;290 ( Pt 2)(Pt 2):419-26. doi: 10.1042/bj2900419. Biochem J. 1993. PMID: 8452530 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous